Dr. Richard Stock on Brachytherapy for Prostate Cancer

Richard Stock, MD
Published: Saturday, Mar 14, 2015



Richard Stock, MD, a professor of radiation oncology at the Icahn School of Medicine at Mount Sinai Hospital, talks about brachytherapy and its benefits for patients with prostate cancer.
 
Brachytherapy, which involves placing radioactive pellets in or near the tumor, limits the dose of radiation only to the prostate by delivering a low dose from within the body over several months.
 
The prostate receives a high amount of radiation therapy biologically, while keeping the radiation dose to the rectal and bladder very low.   


Richard Stock, MD, a professor of radiation oncology at the Icahn School of Medicine at Mount Sinai Hospital, talks about brachytherapy and its benefits for patients with prostate cancer.
 
Brachytherapy, which involves placing radioactive pellets in or near the tumor, limits the dose of radiation only to the prostate by delivering a low dose from within the body over several months.
 
The prostate receives a high amount of radiation therapy biologically, while keeping the radiation dose to the rectal and bladder very low.   

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x